RecruitingNCT02456974
Antibiotic Dosing in Pediatric Intensive Care
Sponsor
University Hospital, Ghent
Enrollment
640 participants
Start Date
May 1, 2012
Study Type
OBSERVATIONAL
Conditions
Summary
Pharmacokinetics of antibiotics in critically ill neonates, infants and children
Eligibility
Min Age: 1 DayMax Age: 16 Years
Plain Language Summary
Simplified for easier understanding
This study monitors how antibiotic levels in the blood change over time in critically ill children in the intensive care unit (ICU). Children's bodies process medications differently than adults, and illness can further change this. By tracking drug levels, researchers want to find the most effective and safe antibiotic dosing for very young and seriously ill patients.
You may be eligible if:
- You are a patient (newborn to 15 years old, weight at least 1.8 kg) admitted to a pediatric ICU
- You are receiving one of the studied antibiotics (such as vancomycin, meropenem, ciprofloxacin, or others) as part of your treatment
- You have an intravenous or arterial line available for blood sampling
You may NOT be eligible if:
- You do not have a catheter in place for blood sampling
- Your parent or guardian has not given consent
- You have a known allergy to the class of antibiotics being studied
- You are on extracorporeal support such as dialysis or ECMO
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PROCEDUREblood sampling in patients receiving amoxicillin-clavulanate as part of routine clinical care
PROCEDUREblood sampling in patients receiving piperacilline-tazobactam as part of routine clinical care.
PROCEDUREblood sampling in patients receiving vancomycin as part of routine clinical care.
PROCEDUREblood sampling in patients receiving teicoplanin as part of routine clinical care.
PROCEDUREblood sampling in patients receiving meropenem as part of routine clinical care.
PROCEDUREblood sampling and urine smapling in patients receiving ciprofloxacin as part of routine clinical care.
PROCEDUREblood sampling in patients receiving amikacin as part of routine clinical care.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02456974
Related Trials
Pharmacokinetics of Kava and Kratom Alone and in Combination
NCT075834071 location
Antibiotics as Adjuncts to Periodontal Therapy:Pharmacokinetic Considerations and Dosing Strategies
NCT046697171 location
Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar/Interchangeable Rapid-Acting Insulin Aspart (I004) and NovoLog® After Single-Dose Subcutaneous Administration to Healthy Volunteers
NCT075601501 location
Comparing the Extent to Which Two Evolocumab Drug Products Are Made Available in the Body After a Single Subcutaneous Dose
NCT074222855 locations
Single Dose Study, Pharmacokinetics of Oxycodone and PF614 Co-Administered With Nafamostat (PF614-MPAR-102)
NCT065007931 location